Analyst firms · Citigroup · MDT
Citigroup MDT price target and rating history
Medtronic plc. (MDT) · Health Care
Citigroup rates Medtronic plc. (MDT) Buy with a $117 price target, as of its latest action on Feb 3, 2026. It has published 6 rating actions on MDT since August 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Citigroup's $117 is 17% above that.
- Current rating
- Buy
- Price target
- $117
- Median target, all firms
- $100
- Actions on MDT
- 6
Citigroup price target on MDT
Every Citigroup rating on MDT
- Feb 3, 2026
- Mar 4, 2025
- Nov 23, 2022
- Jan 19, 2022
- Nov 24, 2021
- Aug 25, 2021
How other firms rate MDT
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Barclays | Equal Weight | $95 | Oct 7, 2026 |
| Needham | Buy | $114 | Aug 27, 2026 |
| UBS | Buy | $100 | Jul 28, 2026 |
| BTIG | Buy | $90 | Jun 4, 2026 |
| Goldman Sachs | Neutral | $84 | May 21, 2026 |
| Citigroup | Buy | $117 | Feb 3, 2026 |
| Wells Fargo | Overweight | $114 | Jan 30, 2026 |
| William Blair | Outperform | Jan 6, 2026 |
Questions about Citigroup and MDT
- What is Citigroup's price target for MDT?
- Citigroup's latest stated price target for Medtronic plc. (MDT) is $117, from its action on Feb 3, 2026.
- What is Citigroup's rating on MDT?
- Citigroup rates MDT Buy, a bullish rating, as of Feb 3, 2026.
- When did Citigroup last change its view on MDT?
- On Feb 3, 2026, Citigroup resumes coverage at Buy, price target $117.
- How does Citigroup's MDT target compare with other analysts?
- Across 7 firms with a MDT price target in the last 12 months, the median target is $100. Citigroup's $117 is 17% above that.
More MDT rating histories
- Barclays3
- Needham7
- UBS4
- BTIG3
- Goldman Sachs4
- Wells Fargo6
- RBC Capital Markets3
- Oppenheimer4
- Morgan Stanley4
- Raymond James3
- Truist Securities3
- Credit Suisse3
All Citigroup ratingsMDT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.